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1. Introduction 
Two basically different kinds of genetic recombina- 
tion are known to occur in RNA-containing viruses. 
Firstly, there is a high-frequency recombination among 
viruses with segmented RNA genomes, such as reo- 
viruses [ 1 J or orthomyxoviruses [2]. This type of 
genetic recombination is due to physical exchange of 
separate RNA molecules (‘segments’) between paren- 
tal genomes and, therefore, may be designated ‘genetic 
reassortment’ [3]. Secondly, relatively low-frequency 
recombination is reported to exist in picornaviruses, 
whose genome is represented by a single RNA mole- 
cule [4,5]. The nature of the latter type of recombi- 
nation is poorly understood, but it is believed to be 
true inheritance in a single RNA molecule of genetic 
properties of both parents [4,5]. Evidence for this 
interpretation has only been provided by purely gene- 
tic techniques and direct biochemical proof that 
recombinants do acquire genetic information from 
more than one parent is lacking. Experimental solu- 
tion of this problem became more feasible when 
recombinants between different poliovirus serotypes 
were obtained (E. A. T., M. S. K., in preparation). 
Well-established differences between the genomes of 
different types of polioviruses ([6-lo], L. I. R., 
E. A. T., V. I. A., submitted) make possible a direct 
comparison of recombinants with each of their parents. 
Here we report results showing that some poly- 
peptides coded for by the genome of a type l/type 3 
poliovirus recombinant are indistinguishable from the 
corresponding polypeptides of the type 1 parent, 
whereas ome other recombinant-specific polypeptides 
appear to be of the type 3 origin. These results are 
the first direct biochemical evidence for intermolec- 
ular recombination between RNA genomes. 
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2. Methods 
Poliovirus type 1, MgrS7r, is a two-step derivative 
of strain Mahoney, which was selected consecutively 
for resistance to guanidine-HCl(60 pg/ml) and ethyl- 
2-methylthio-4-methyl-5pyrimidine carboxylate (S7, 
100 pg/ml). It was cloned twice in the presence of S7. 
Poliovirus type 3, ts557, is a cloned two-step deriva- 
tive of strain 452/62IIID (originally isolated from a 
human polio case);first, a tr mutant of the latter strain 
was selected by growing the virus at 4O”C, and then a 
ts mutation was introduced by 5fluorouracyl muta- 
genesis. Genetic experiments (to be reported else- 
where) allowed us to place the ts557 mutation 
between the guanidine locus and the 3’-end of the 
genome (fig.1). 
The recombinant, MgrS7rlts557, was obtained upon 
mixed infection of HeLa cells with parental viruses at 
a multiplicity of infection with each virus of -20 
p.f.u./cell. Intertypic recombinants in the progeny 
of the mixed infection were scored by plaque assay 
in Macacu rhesus kidney cell cultures under condi- 
tions restrictive for either parent alone, namely, in 
the presence of an antiserum against polio type 1 
(inhibiting the type lparent) and guanidme-HCl 
(60 pg/ml); in addition, the assay was carried out 
at 40°C (both latter conditions were inhibitory for 
the type 3 parent). 
Labeling of virus-specific polypeptides was 
achieved by incubation of virus-infected HeLa cells 
with [35S]methionine from 2-4 h postinfection. The 
cytoplasmic extracts were prepared by treating the 
cell suspension in 0.15 M NaCl, 5 mM EDTA, 50 mM 
Tris-HCl (pH 7.8) 0.02% Na-azide with 1% NP-40 
at 4°C for 5 min followed by low-speed centrifuga- 
tion. As a source of capsid polypeptides, preparations 
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of virions purified essentially as in [ 1 l] were used. 
Partial proteolysis products were analysed essentially 
as in [12,13]. The following proteolytic enzymes 
were utilized: a protease from Streptomyces 
cuespitosus, chymotrypsin, and papain. 
(a) NHp PRECURSOR POLYOROTEIN COOH 
---- - 
VP4 VP2 VP2 VP1 WCVPX NCVPQ 
----------____ 
’ 0 TYPE1 5’ s7* 
I 
3. Results and discussion 
Some phenotypic properties of the type l/type 3 
polio recombinant used in this study are presented in 
table 1. It is clearly seen that the neutralization prop- 
erties as well as sensitivity to S7, a non-selected capsid 
polypeptide marker [4], both indicate that at least 
some capsid polypeptides of the recombinant are 
inherited from the type 3 parent, whereas the resis- 
Fig.1. (a) Approximate positions of the sequences corre- 
spending to some capsid and non-capsid polypeptides in the 
poliovirus polyprotein. (b) Schematic representation of the 
parental and recombinant genomes. Positions of the genetic 
loci are given arbitrxily, but the S7 and ts557 loci are known 
to be situated in the capsid and non-capsid regions of the 
genome, respectively, and the g-locus should be placed 
between the S7 and ts557 sites. 
Fig.2. Partial proteolysis products of the capsid polypeptides. Purified preparations of vhions of poliovirus type 1 (Tl), poliovirus 
type 3 (T3), and recombinant MgrS7r/ts557 (R1/3) were subjected to electrophoresis in a SDS-containing polyacrylamide slab, 
gel regions containing capsid polypeptides were excised, treated with a protease from S. caespitoms, and the resulting products 
were subjected to the seconddimension electrophoresis. 
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tance to guanidine and the tr phenotype are similar to 
those of the type 1 parent. A schematic representa- 
tion of the recombinant genome which is compatible 
with the data of table 1, is given in fig. 1. 
One can argue, however, that the phenotypic prop- 
erties of MgrS7r/ts557 may,in principle, be explained 
by assuming that the type 3 parent had not under- 
gone, upon mixed infection, any recombinational 
event, but rather two, or even one, mutations rendered 
the virus both guanidine- and temperature-resistant. 
Against the latter interpretation two genetic observa- 
tions may be adduced: 
The number of plaques formed under conditions 
restrictive for either parent in the progeny of the 
type l/type 3 mixed infection was -15fold 
higher (“9 X 10e5) than in the progeny of the 
single type 3 infection (-6 X 10”); 
The clones of type 3 virus which were selected 
for the ability to reproduce in the presence of 
guanidine were so far invariably found to be 
guanidine-dependent (i.e., requiring guanidine for 
reproduction) rather than guanidine-resistant 
(i.e ., capable of reproducing both in the presence 
and the absence of guanidine). 
On the other hand, MgrS7*/&557 displayed a guani- 
dine-resistant phenotype (table 1) and it is only natu- 
ral to assume that it acquired this phenotype from its 
type 1 parent. Although this argument may suggest 
that the virus with the combined properties of the 
type 1 and type 3 parents is actually a recombinant, 
direct biochemical proof of this notion is desirable. 
If the genome of our provisional recombinant is 
properly outlined in fig. 1, then it should have capsid 
Table 1 
Phenotypic properties of the recombinant and its parentsa 
Conditions of assay Type 1 Type 3 Recombinant 
Control >376 74 a56 
Antipolio 1 serum <b 280 >60 
Antipolio 3 serum 2400 <l <OS 
s7 2400 <l <OS 
Guanidine >400 <I 257 
40°C 2400 <I a53 
a Stocks of the three viruses were plaque-titrated in M. rhesus 
kidney cell cultures at 37”C, except he last line. The results 
are expressed in p.f.u./ml X lo-‘. 2 indicates that a rela- 
tively high number of plaques developed in each flask, so 
that some plaque overlapping could not be excluded. Con- 
centrations of the inhibitors are listed in section 2 
T7 WV3 T=8 
Fig.3. Partial proteolysis products of the NCVP2 polypep- 
tides. Labeled extracts from the cells infected with the appro- 
priate virus were subjected to electrophoresis in a SDS-con- 
taining polyacrylamide slab, gel regions containing NCVPZ 
were excised, treated with a protease from S. cuespifosus, 
and the resulting products were subjected to electrophoresis. 
polypeptides of the type 3 parent and at least some 
non-capsid polypeptides of the type 1 virus. Partial 
proteolysis mapping allowed us to distinguish capsid 
as well as some non-capsid polypeptides of polio- 
viruses belonging to different serotypes (L. I. R., 
E. A. T., U. I. A., submitted). Therefore, using this 
technique we have compared capsid (VPl, VP2 and 
VP3) and non-capsid (NCVP2) polypeptides of the 
three viruses, MgrS7*/ts557 and both its presumptive 
parents. 
The results obtained with the protease from 
S. caespitosus are presented in fig.2,3. The capsid 
polypeptides of the recombinant are very, similar, per- 
haps identical, to those of the type 3 virus (fig.2). On 
the other hand, the NCW2 polypeptide of the recom- 
binant is indistinguishable from the corresponding 
polypeptide of its type 1 parent, but reveals repro- 
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ducible differences with NCVP2 of the type 3 virus. 
Similar results were obtained with the three proteases 
utilised. This is direct evidence for intermolecular 
genetic recombination among RNA genomes. 
Another point also deserves comment. It is usually 
assumed that the locus responsible for the sensitivity 
of poliovirus reproduction to guanidine is located in 
the capsid region of the genome [4]. However, the 
recombinant studied here appears to acquire the 
guanidine locus from one parent and capsid polypep- 
tides including VP1 (the most S’-end distal capsid 
polypeptide) from the other. This finding suggests 
that the guanidine locus lies outside the capsid region 
[5], but more definitive statement o this end requires 
detailed studies of different polypeptides. Such studies 
aimed at more precise localisation of the guanidine 
locus and some other genetic loci, using this approach, 
are in progress. 
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